Insta
After Adverse Reaction In United Kingdom, Serum Institute Halts Indian Trials Of Oxford-AstraZeneca Covid-19 Vaccine
Serum Institute of India (Pic Via Twitter)
Pune-based Serum Institute of India (SII), world's largest vaccine maker by volume, on Thursday (10 September) halted the trials of Oxford-AstraZeneca's Covid-19 vaccine in India until the British-Swedish drugmaker AstraZeneca restarts them.
"We are reviewing the situation and pausing India trials till AstraZeneca restarts them," Serum Institute said in a tweet.
The development comes a day after AstraZeneca had paused a late-stage trial of its Covid-19 vaccine following a suspected adverse reaction in a study participant in UK.
Following the incident, AstraZeneca had put on hold the trials of the vaccine and would only restart them after a review by a data safety monitoring board.
AstraZeneca has partnered with Serum Institute for manufacturing of one billion doses of the experimental Covid-19 vaccine.
Earlier on Wednesday (9 September), the Serum Institute had said that Indian trials of the vaccine will continue as the company had not faced any issues in the trials. It had also said that the AstraZeneca had paused the trials for review and it could restart soon.
The Serum Institute's latest decision comes after the DCGI issued a show-cause notice to the vaccine maker for not informing it about AstraZeneca suspending the clinical trials of the Oxford vaccine candidate in other countries, and also for not submitting casualty analysis of the "reported serious adverse events", reports Business Today.
Support Swarajya's 50 Ground Reports Project & Sponsor A Story
Every general election Swarajya does a 50 ground reports project.
Aimed only at serious readers and those who appreciate the nuances of political undercurrents, the project provides a sense of India's electoral landscape. As you know, these reports are produced after considerable investment of travel, time and effort on the ground.
This time too we've kicked off the project in style and have covered over 30 constituencies already. If you're someone who appreciates such work and have enjoyed our coverage please consider sponsoring a ground report for just Rs 2999 to Rs 19,999 - it goes a long way in helping us produce more quality reportage.
You can also back this project by becoming a subscriber for as little as Rs 999 - so do click on this links and choose a plan that suits you and back us.
Click below to contribute.
Latest
